coronavirus vaccine supply chain
ID 182903010 © Akesin |


The goal is to bring a much needed COVID-19 vaccine to emerging and developing nations.

The agreement establishes integrated logistics to enable efficient worldwide distribution of COVAXX’s COVID-19 vaccine.

The aim is to distribute up to a billion doses of the COVAXX synthetic vaccine worldwide in 2021.

HAUPPAUGE, NY (October 26, 2020) – COVAXX, a U.S. company developing a multitope synthetic peptide-based vaccine to fight COVID-19, has announced a global ...

Subscription required for Premium stories

In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium
Premium subscriber
New Premium subscriber REGISTER

Comment on this article

You must be logged in to post a comment.